Regulation of the release of tumour necrosis factor (TNF)alpha and soluble TNF receptor by gamma irradiation and interferon gamma in Ewing's sarcoma/peripheral primitive neuroectodermal tumour cells
- PMID: 9201246
- PMCID: PMC12201176
- DOI: 10.1007/BF01208634
Regulation of the release of tumour necrosis factor (TNF)alpha and soluble TNF receptor by gamma irradiation and interferon gamma in Ewing's sarcoma/peripheral primitive neuroectodermal tumour cells
Abstract
This study analyses the production of tumour necrosis factor (TNF)alpha and soluble TNF receptor (sTNF-R) before and after exposure to gamma irradiation and interferon gamma (IFN gamma) in 12 cell lines derived from Ewing's sarcoma (ES)/peripheral primitive neuroectodermal tumours (pPNET). Supernatants from ES/pPNET cell cultures were tested in a TNF alpha-specific amplified enzyme-linked immunosorbent assay (ELISA), a bioassay, and sTNF-Rp55 and sTNF-Rp75 ELISA. The tumour cell lines released minimal amounts of TNF alpha, prominent amounts of sTNF-Rp55 (7/12 cell lines) and no sTNF-Rp75. Exposure to gamma irradiation (5 Gy) either induced (3/12) cell lines) or up-regulated (3/12 cell lines) TNF alpha release without changing sTNF-Rp55 and sTNF-Rp75 levels. Priming of cultures with recombinant human IFN gamma (rhIFN gamma) markedly enhanced TNF alpha secretion in the radiation-responsive cell lines and had no influence on sTNF-Rp55 and sTNF-Rp75 levels. rhIFN gamma affected the magnitude rather than the sensitivity of the radiation response. The TNF alpha secreted was bioactive, as shown by its cytotoxic effect of WEHI-164 cells, and neutralization of its activity by anti-TNF alpha monoclonal antibody. Herbimycin A (a tyrosine-specific protein kinase inhibitor) but not calphostin C (a protein kinase C inhibitor), H89 (a protein kinase A inhibitor), AA-COCF3 (a specific inhibitor of phospholipase A2) and MK-886 (a specific inhibitor of 5-lipoxygenase) abrogated gamma-irradiation-stimulated TNF alpha release. The antioxidants N-acetylcysteine, nordihydroguaiaretic acid and mepacrine dose-dependently inhibited gamma-irradiation-mediated TNF alpha production. Collectively our findings indicate that IFN gamma priming potentiates the secretion of bioactive TNF alpha by ES/pPNET cells in response to gamma irradiation without affecting sTNF-R release. The data suggest a requirement for protein tyrosine kinase activity and a role for reactive oxygen species in the gamma-irradiation-mediated intracellular signalling pathway leading to TNF alpha production.
Similar articles
-
Interferon gamma and tumour necrosis factor alpha induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro.J Cancer Res Clin Oncol. 1993;119(10):615-21. doi: 10.1007/BF01372725. J Cancer Res Clin Oncol. 1993. PMID: 8335680 Free PMC article.
-
Ewing's sarcoma and peripheral primitive neuroectodermal tumor cells produce large quantities of bioactive tumor necrosis factor-alpha (TNF-alpha) after radiation exposure.Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1414-25. doi: 10.1016/s0360-3016(03)00418-8. Int J Radiat Oncol Biol Phys. 2003. PMID: 12873688
-
Expression of functional very late antigen-alpha 1, -alpha 2, -alpha 3 and -alpha 6 integrins on Ewing's sarcoma and primitive peripheral neuroectodermal tumour cells and modulation by interferon-gamma and tumour necrosis factor-alpha.Eur J Cancer. 1994;30A(14):2119-25. doi: 10.1016/0959-8049(94)00346-7. Eur J Cancer. 1994. PMID: 7857712
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. doi: 10.3310/hta10420. Health Technol Assess. 2006. PMID: 17049139
Cited by
-
Radiation increases invasion of gene-modified mesenchymal stem cells into tumors.Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):843-53. doi: 10.1016/j.ijrobp.2008.06.1953. Epub 2008 Oct 11. Int J Radiat Oncol Biol Phys. 2009. PMID: 18849123 Free PMC article.
-
Prolyl hydroxylase domain 3 influences the radiotherapy efficacy of pancreatic cancer cells by targeting hypoxia-inducible factor-1α.Onco Targets Ther. 2018 Nov 29;11:8507-8515. doi: 10.2147/OTT.S187615. eCollection 2018. Onco Targets Ther. 2018. PMID: 30555241 Free PMC article.
-
TGF-beta1 influence on TNF-alpha production and sTNF-Rs shedding in a coculture of colon carcinoma cell spheroids with normal cells.In Vitro Cell Dev Biol Anim. 2009 Jul-Aug;45(7):371-7. doi: 10.1007/s11626-009-9190-9. Epub 2009 Mar 20. In Vitro Cell Dev Biol Anim. 2009. PMID: 19301076
-
Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing's Sarcoma, Enhancing T Cell Cytotoxicity.Cells. 2021 Nov 8;10(11):3070. doi: 10.3390/cells10113070. Cells. 2021. PMID: 34831294 Free PMC article.
-
Cytokine screening identifies TNF to potentially enhance immunogenicity of pediatric sarcomas.Front Immunol. 2024 Dec 11;15:1347404. doi: 10.3389/fimmu.2024.1347404. eCollection 2024. Front Immunol. 2024. PMID: 39723214 Free PMC article.
References
-
- Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M (1991) MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 67:1886–1893 - PubMed
-
- Aruoma OI, Halliwell B, Hoey BM, Butler J (1989) The antioxidant action ofN-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radical Biol Med 6:593–597 - PubMed
-
- Bertolini DR, Nedwin G, Bringman T, Smith D, Mundy GR (1986) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factor. Nature 319:516–518 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical